A Brisbane biotech that makes needle free vaccine delivery patches has been tapped by a global charity to help fight typhoid, the life-threatening disease that infects millions of people every year. Vaxxas will conduct clinical studies and a trial of a typhoid vaccine delivered through its needle-free vaccine patch technology platform after receiving $5.4 million…

The post Aussie biotech to trial needle-free typhoid vaccinations appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.